Published in J Virol on March 01, 1992
Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J Virol (1994) 4.67
Vaccinia virus A17L open reading frame encodes an essential component of nascent viral membranes that is required to initiate morphogenesis. J Virol (1996) 2.77
Poxvirus orthologous clusters: toward defining the minimum essential poxvirus genome. J Virol (2003) 2.70
Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. J Virol (1993) 2.64
Vaccinia virus B1 kinase: phenotypic analysis of temperature-sensitive mutants and enzymatic characterization of recombinant proteins. J Virol (1992) 2.07
The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus. J Virol (1998) 2.05
Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. J Virol (1996) 2.03
Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. J Virol (1996) 2.01
Characterization of early stages in vaccinia virus membrane biogenesis: implications of the 21-kilodalton protein and a newly identified 15-kilodalton envelope protein. J Virol (1997) 2.00
Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera. J Virol (2001) 1.98
Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc Natl Acad Sci U S A (1998) 1.97
Vaccinia virus infection disrupts microtubule organization and centrosome function. EMBO J (2000) 1.96
Vaccinia virus 15-kilodalton (A14L) protein is essential for assembly and attachment of viral crescents to virosomes. J Virol (1998) 1.91
Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis. J Virol (1995) 1.89
A novel immunogold cryoelectron microscopic approach to investigate the structure of the intracellular and extracellular forms of vaccinia virus. EMBO J (1996) 1.88
The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus. J Virol (1997) 1.87
The vaccinia virus 14-kilodalton fusion protein forms a stable complex with the processed protein encoded by the vaccinia virus A17L gene. J Virol (1993) 1.86
Pox proteomics: mass spectrometry analysis and identification of Vaccinia virion proteins. Virol J (2006) 1.69
Vaccinia virus morphogenesis is blocked by a temperature-sensitive mutation in the I7 gene that encodes a virion component. J Virol (1993) 1.68
Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation. J Virol (1999) 1.68
The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein. J Virol (2001) 1.41
Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence. J Virol (2000) 1.38
Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain. J Virol (1998) 1.36
Transcription of viral late genes is dependent on expression of the viral intermediate gene G8R in cells infected with an inducible conditional-lethal mutant vaccinia virus. J Virol (1992) 1.28
Golgi network targeting and plasma membrane internalization signals in vaccinia virus B5R envelope protein. J Virol (2000) 1.25
The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation. J Virol (1998) 1.23
Smallpox vaccines: targets of protective immunity. Immunol Rev (2011) 1.21
Inducible expression of the vaccinia virus A17L gene provides a synchronized system to monitor sorting of viral proteins during morphogenesis. J Virol (1996) 1.20
The vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis. J Virol (2000) 1.16
Vaccinia virus A36R membrane protein provides a direct link between intracellular enveloped virions and the microtubule motor kinesin. J Virol (2004) 1.12
Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon. J Virol (2000) 1.12
Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins. J Virol (2006) 1.12
Vaccinia virus WR gene A5L is required for morphogenesis of mature virions. J Virol (1999) 1.10
Envelope formation is blocked by mutation of a sequence related to the HKD phospholipid metabolism motif in the vaccinia virus F13L protein. J Virol (1999) 1.08
The vaccinia virus A14.5L gene encodes a hydrophobic 53-amino-acid virion membrane protein that enhances virulence in mice and is conserved among vertebrate poxviruses. J Virol (2000) 1.08
Mapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteins. J Virol (2003) 1.07
The vaccinia virus B5 protein requires A34 for efficient intracellular trafficking from the endoplasmic reticulum to the site of wrapping and incorporation into progeny virions. J Virol (2007) 1.01
A novel bat herpesvirus encodes homologues of major histocompatibility complex classes I and II, C-type lectin, and a unique family of immune-related genes. J Virol (2012) 1.00
The ps/hr gene (B5R open reading frame homolog) of rabbitpox virus controls pock color, is a component of extracellular enveloped virus, and is secreted into the medium. J Virol (1993) 0.99
Vaccinia virus F13L protein with a conserved phospholipase catalytic motif induces colocalization of the B5R envelope glycoprotein in post-Golgi vesicles. J Virol (2001) 0.94
Analysis of a vaccinia virus mutant expressing a nonpalmitylated form of p37, a mediator of virion envelopment. J Virol (1998) 0.91
The structure of the poxvirus A33 protein reveals a dimer of unique C-type lectin-like domains. J Virol (2009) 0.90
Vaccinia virus A34 glycoprotein determines the protein composition of the extracellular virus envelope. J Virol (2007) 0.89
Characterization of the vaccinia virus A35R protein and its role in virulence. J Virol (2006) 0.89
Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane. J Gen Virol (2009) 0.88
Role of receptor-mediated endocytosis in the formation of vaccinia virus extracellular enveloped particles. J Virol (2005) 0.88
Vaccinia virus induces Ca2+-independent cell-matrix adhesion during the motile phase of infection. J Virol (1998) 0.86
A36-dependent actin filament nucleation promotes release of vaccinia virus. PLoS Pathog (2013) 0.85
The host phosphoinositide 5-phosphatase SHIP2 regulates dissemination of vaccinia virus. J Virol (2011) 0.84
Cloak and Dagger: Alternative Immune Evasion and Modulation Strategies of Poxviruses. Viruses (2015) 0.84
There is an A33-dependent mechanism for the incorporation of B5-GFP into vaccinia virus extracellular enveloped virions. Virology (2010) 0.83
Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine. J Virol (2012) 0.82
Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model. PLoS One (2013) 0.81
Epitope mapping by random peptide phage display reveals essential residues for vaccinia extracellular enveloped virion spread. Virol J (2012) 0.81
The inability of vaccinia virus A33R protein to form intermolecular disulfide-bonded homodimers does not affect the production of infectious extracellular virus. Virology (2010) 0.80
Vaccinia virus B5 protein affects the glycosylation, localization and stability of the A34 protein. J Gen Virol (2010) 0.80
Protein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virions. J Gen Virol (2012) 0.78
The A33-dependent incorporation of B5 into extracellular enveloped vaccinia virions is mediated through an interaction between their lumenal domains. J Virol (2012) 0.78
Increased interaction between vaccinia virus proteins A33 and B5 is detrimental to infectious extracellular enveloped virion production. J Virol (2012) 0.77
Protein Primary Structure of the Vaccinia Virion at Increased Resolution J Virol (2016) 0.76
Transport and stability of the vaccinia virus A34 protein is affected by the A33 protein. J Gen Virol (2012) 0.76
Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer. PLoS Pathog (2015) 0.75
Recombinant Sheep Pox Virus Proteins Elicit Neutralizing Antibodies. Viruses (2016) 0.75
Vaccinia Virus Proteins A36 and F12/E2 Show Strong Preferences for Different KLC Isoforms. Traffic (2017) 0.75
Improved tools for biological sequence comparison. Proc Natl Acad Sci U S A (1988) 193.60
Patterns of amino acids near signal-sequence cleavage sites. Eur J Biochem (1983) 26.68
The complete DNA sequence of vaccinia virus. Virology (1990) 7.76
High-expression vectors with multiple cloning sites for construction of trpE fusion genes: pATH vectors. Methods Enzymol (1991) 6.25
Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature (1983) 5.25
On the predictive recognition of signal peptide sequences. Virus Res (1985) 5.21
Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J Virol (1991) 5.14
Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. J Virol (1988) 4.92
Two distinct classes of carbohydrate-recognition domains in animal lectins. J Biol Chem (1988) 4.79
Glycobiology. Annu Rev Biochem (1988) 4.51
Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. J Gen Virol (1980) 4.24
Primary structure of human transferrin receptor deduced from the mRNA sequence. Nature (1984) 4.04
Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature (1985) 3.62
Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination. Virology (1971) 3.57
Poxvirus pathogenesis. Microbiol Rev (1991) 3.54
Differences between extracellular and intracellular forms of poxvirus and their implications. Prog Med Virol (1973) 3.19
Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane. J Virol (1990) 3.18
Vaccinia virus reexamined: development and release. Virology (1976) 3.15
Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus. J Virol (1985) 3.06
Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus. J Virol (1979) 2.94
Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genes. Proc Natl Acad Sci U S A (1987) 2.84
Polypeptide composition of extracellular enveloped vaccinia virus. J Virol (1978) 2.79
Presence of haemagglutinin in the envelope of extracellular vaccinia virus particles. J Gen Virol (1976) 2.78
Localization and fine structure of a vaccinia virus gene encoding an envelope antigen. J Virol (1986) 2.64
Vaccinia virus-encoded eIF-2 alpha homolog abrogates the antiviral effect of interferon. Virology (1991) 2.63
A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers. J Virol (1987) 2.53
Nucleotide sequence of the vaccinia virus hemagglutinin gene. Virology (1986) 2.49
Conserved TAAAT motif in vaccinia virus late promoters: overlapping TATA box and site of transcription initiation. EMBO J (1986) 2.41
IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress. Nucleic Acids Res (1990) 2.41
Mechanism of vaccinia virus release and its specific inhibition by N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine. J Virol (1979) 2.33
The preparation of orthopoxvirus DNA. J Virol Methods (1981) 2.28
Deletion of the vaccinia virus growth factor gene reduces virus virulence. J Virol (1988) 2.10
Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat. J Gen Virol (1991) 1.96
A mutation in the gene encoding the vaccinia virus 37,000-M(r) protein confers resistance to an inhibitor of virus envelopment and release. J Virol (1991) 1.90
Inducible gene expression from vaccinia virus vectors. Virology (1990) 1.76
Inducer-dependent conditional-lethal mutant animal viruses. Proc Natl Acad Sci U S A (1991) 1.72
A dominant selectable marker for the construction of recombinant poxviruses. Gene (1988) 1.72
Restoration of specific myxovirus receptors to asialoerythrocytes by incorporation of sialic acid with pure sialyltransferases. J Biol Chem (1979) 1.53
Transcriptional mapping and nucleotide sequence of a vaccinia virus gene encoding a polypeptide with extensive homology to DNA ligases. Nucleic Acids Res (1989) 1.43
Molecular genetic analysis of a vaccinia virus gene with an essential role in DNA replication. J Virol (1987) 1.43
Sequence analysis of an 11.2 kilobase, near-terminal, BamHI fragment of fowlpox virus. J Gen Virol (1988) 1.39
Protection against poxviruses. Proc R Soc Med (1969) 1.38
Fowlpox virus as a vector in non-avian species. Vaccine (1988) 1.29
The effect of cytochalasin D and monensin on enveloped vaccinia virus release. Arch Virol (1982) 1.20
Poxviruses: an emerging portrait of biological strategy. Cell (1990) 1.20
A tandemly-oriented late gene cluster within the vaccinia virus genome. Nucleic Acids Res (1986) 1.20
Vaccinia virus DNA ligase is nonessential for virus replication: recovery of plasmids from virus-infected cells. Virology (1991) 1.16
Insertional mutagenesis of the vaccinia virus gene encoding a type I DNA topoisomerase: evidence that the gene is essential for virus growth. Virology (1989) 1.10
Biogenesis of vaccinia. Effects of inhibitors of glycosylation on virus-mediated activities. Virology (1977) 1.06
Effect of glycosylation inhibitors on the release of enveloped vaccinia virus. J Virol (1982) 0.93
Homology of cytotoxic protein of eosinophilic leukocytes with IgE receptor Fc epsilon RII: implications for its structure and function. Mol Immunol (1989) 0.80
General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol (1984) 10.98
Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc Natl Acad Sci U S A (1982) 7.81
Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1985) 5.42
Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature (1983) 5.25
Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proc Natl Acad Sci U S A (1983) 4.69
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med (1998) 4.13
Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA. Gene (1983) 3.94
A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc Natl Acad Sci U S A (2000) 3.69
Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature (1985) 3.62
Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell (1995) 3.51
A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell (1992) 3.36
Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells. Nature (1984) 3.21
Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature (1984) 3.03
Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus. Virology (1994) 2.89
The effects of metabolic inhibition on intracellular calcium and pH in isolated rat ventricular cells. J Physiol (1989) 2.86
Vaccinia virus expression vectors. J Gen Virol (1986) 2.84
Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J Exp Med (1988) 2.73
A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology (1992) 2.67
The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology (1993) 2.66
Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine. J Gen Virol (1998) 2.55
IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress. Nucleic Acids Res (1990) 2.41
Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein. Science (1987) 2.24
Vaccinia virus intracellular mature virions contain only one lipid membrane. J Virol (1999) 2.24
Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. J Gen Virol (1986) 2.16
Intracellular and extracellular vaccinia virions enter cells by different mechanisms. J Gen Virol (1998) 2.14
Vaccinia virus utilizes microtubules for movement to the cell surface. J Cell Biol (2001) 2.10
The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J Virol (2000) 2.08
Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J Virol (1995) 2.07
EGTA purity and the buffering of calcium ions in physiological solutions. Am J Physiol (1984) 2.03
Transient inhibition of polyoma virus synthesis by Sendai virus (parainfluenza I). I. Demonstration and nature of the inhibition by inactivated virus. J Virol (1972) 2.01
Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. J Virol (1996) 2.01
Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc Natl Acad Sci U S A (1998) 1.97
Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J Immunol (1998) 1.94
A novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors. J Virol (1997) 1.86
Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion. J Gen Virol (1998) 1.81
K201 modulates excitation-contraction coupling and spontaneous Ca2+ release in normal adult rabbit ventricular cardiomyocytes. Cardiovasc Res (2007) 1.76
Inducible gene expression from vaccinia virus vectors. Virology (1990) 1.76
Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine (1998) 1.74
Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus. J Virol (1986) 1.73
Inverse relation between prostate-specific antigen and insulin-like growth factor-binding protein 3 in bone metastases and serum of patients with prostate cancer. Lancet (1999) 1.70
Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation. J Virol (1999) 1.68
Cytokine receptors encoded by poxviruses: a lesson in cytokine biology. Immunol Today (1995) 1.68
Comparative risks and costs of male and female sterilization. Am J Public Health (1985) 1.65
Potentiometric measurements of stoichiometric and apparent affinity constants of EGTA for protons and divalent ions including calcium. Biochim Biophys Acta (1985) 1.65
Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes. J Virol (1986) 1.62
Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus. J Clin Pathol (1990) 1.57
Calcium-induced calcium release activates contraction in intact cardiac cells. Pflugers Arch (1989) 1.57
The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles. Virology (2000) 1.56
Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever. J Gen Virol (1997) 1.54
The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles. J Gen Virol (2000) 1.52
Vaccinia virus gene B1R encodes a 34-kDa serine/threonine protein kinase that localizes in cytoplasmic factories and is packaged into virions. Virology (1992) 1.50
Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation. J Gen Virol (1997) 1.49
The genome sequence of Yaba-like disease virus, a yatapoxvirus. Virology (2001) 1.48
The influence of tackle parameters on the propensity for injury in international football. Am J Sports Med (2004) 1.47
Lack of HIV infection and condom use in licensed prostitutes. Lancet (1986) 1.46
Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors. J Gen Virol (1999) 1.46
Preliminary studies of absorption and excretion of benoxaprofen in man. Br J Clin Pharmacol (1977) 1.46
Replication of the influenza virus genome. Virology (1982) 1.45
Plasmodium knowlesi sporozoite antigen: expression by infectious recombinant vaccinia virus. Science (1984) 1.42
S100A1: a regulator of myocardial contractility. Proc Natl Acad Sci U S A (2001) 1.42
Testicular prosthesis placement: a new technique. BJU Int (1999) 1.40
A mechanism for the inhibition of fever by a virus. Proc Natl Acad Sci U S A (1996) 1.39
Field evaluation of Haemophilus somnus bacterin. Vet Med Small Anim Clin (1977) 1.38
Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence. J Virol (2000) 1.38
Circumcision as a risk factor for urethritis in racial groups. Am J Public Health (1987) 1.38
The relationship between intracellular calcium and contraction in calcium-overloaded ferret papillary muscles. J Physiol (1985) 1.37
Purified multiplication-stimulating activity from rat liver cell conditioned medium: comparison of biological activities with calf serum, insulin, and somatomedin. J Cell Physiol (1974) 1.37
Difficulties encountered in the search for the etiologic agents of destructive periodontal diseases. J Clin Periodontol (1987) 1.35
Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M(r) 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model. Virology (1995) 1.34
The PA influenza virus polymerase subunit is a phosphorylated protein. J Gen Virol (1998) 1.33
Antibody neutralization of the extracellular enveloped form of vaccinia virus. Virology (2001) 1.32
Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice. J Gen Virol (1998) 1.32
Simultaneous measurements of action potential duration and intracellular ATP in isolated ferret hearts exposed to cyanide. Circ Res (1989) 1.31
An evaluation of direct access radiology in general practice. J R Coll Gen Pract (1979) 1.31
Anchoring a secreted plasmodium antigen on the surface of recombinant vaccinia virus-infected cells increases its immunogenicity. Mol Cell Biol (1986) 1.31
Metabolic consequences of increasing intracellular calcium and force production in perfused ferret hearts. J Physiol (1986) 1.30
A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae. J Gen Virol (1999) 1.29
Immunogenicity of a Haemophilus somnus bacterin in cattle. Am J Vet Res (1978) 1.27
The electrophysiological and mechanical effects of 2,3-butane-dione monoxime and cytochalasin-D in the Langendorff perfused rabbit heart. Exp Physiol (2004) 1.25
Clinical performance of a rule-based decision support system for mechanical ventilation of ARDS patients. Proc Annu Symp Comput Appl Med Care (1993) 1.23
Virus-induced cell motility. J Virol (1998) 1.23
The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation. J Virol (1998) 1.23
Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptor-mediated Ca(2+) leak from the sarcoplasmic reticulum and increases contractility. Circ Res (2001) 1.21
Nucleotide sequence of 21.8 kbp of variola major virus strain Harvey and comparison with vaccinia virus. J Gen Virol (1992) 1.20
Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevisiae. J Biol Chem (1991) 1.20
Vaccinia virus core protein VP8 is required for virus infectivity, but not for core protein processing or for INV and EEV formation. Virology (1994) 1.20
The contribution of intracellular acidosis to the decline of developed pressure in ferret hearts exposed to cyanide. J Physiol (1987) 1.20
A vaccinia serine protease inhibitor which prevents virus-induced cell fusion. J Gen Virol (1992) 1.20
Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol (2000) 1.19
The mechanism of early contractile failure of isolated rat ventricular myocytes subjected to complete metabolic inhibition. J Physiol (1989) 1.19
Rapid method for the purification of DNA from subgingival microorganisms. Oral Microbiol Immunol (1989) 1.19
Metabolic changes during ischaemia and their role in contractile failure in isolated ferret hearts. J Physiol (1992) 1.19
Vaccinia DNA ligase complements Saccharomyces cerevisiae cdc9, localizes in cytoplasmic factories and affects virulence and virus sensitivity to DNA damaging agents. EMBO J (1991) 1.19
Heterogeneous changes in action potential and intracellular Ca2+ in left ventricular myocyte sub-types from rabbits with heart failure. Cardiovasc Res (2000) 1.19
The effects of 2,3-butanedione monoxime on initial heat, tension, and aequorin light output of ferret papillary muscles. Pflugers Arch (1990) 1.19
Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family. Virology (1991) 1.18
Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival. Br J Cancer (2000) 1.17